药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
BA-2664
Glycine betaine
The therapeutic efficacy of Revefenacin can be decreased when used in combination with Glycine betaine.
BA-2664
Aprotinin
The therapeutic efficacy of Revefenacin can be decreased when used in combination with Aprotinin.
BA-2664
Regramostim
The therapeutic efficacy of Revefenacin can be decreased when used in combination with Regramostim.
BA-2664
Phenserine
The therapeutic efficacy of Revefenacin can be decreased when used in combination with Phenserine.
BA-2664
Huperzine A
The therapeutic efficacy of Revefenacin can be decreased when used in combination with Huperzine A.
BA-2664
Thiotepa
The therapeutic efficacy of Revefenacin can be decreased when used in combination with Thiotepa.
BA-2664
1,10-Phenanthroline
The therapeutic efficacy of Revefenacin can be decreased when used in combination with 1,10-Phenanthroline.
BA-2664
Cannabinol
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Cannabinol.
BA-2664
Palmidrol
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Palmidrol.
BA-2664
WIN 55212-2
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with WIN 55212-2.
BA-2664
Surinabant
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Surinabant.
BA-2664
Ibipinabant
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Ibipinabant.
BA-2664
Ajulemic acid
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Ajulemic acid.
BA-2664
GW842166
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with GW842166.
BA-2664
Taranabant
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Taranabant.
BA-2664
Rimonabant
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with Rimonabant.
BA-2664
SLV319
The risk or severity of Tachycardia and drowsiness can be increased when Revefenacin is combined with SLV319.
BA-2664
Epitizide
The serum concentration of Epitizide can be increased when it is combined with Revefenacin.
BA-2664
Cyclopenthiazide
The serum concentration of Cyclopenthiazide can be increased when it is combined with Revefenacin.
BA-2664
Cimetropium
The risk or severity of adverse effects can be increased when Revefenacin is combined with Cimetropium.